MaaT Pharma Announces 2022 Annual Results and Provides a Business Over...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 5, 2023

U.S. Institute of Peace Opens Nominations for 2023 Women Building Peace Award • Air Canada's Inaugural Amsterdam-Montreal Route Takes Off; Uplifts Sustainable Aviation Fuel in Amsterdam • Brand Strength Assumes Greater Importance for Private Equity Firms as Competition for Deals and LP Dollars Intensifies • CatalYm Announces Initial Data from Ongoing Phase 2a Trial Evaluating GDF-15-targeting Antibody Visugromab in Combination with N • Cupshe Celebrates 8th Birthday with Exclusive Collection in Collaboration with Chanel Iman, Heather Rae El Moussa, and Brittany • Government of Canada releases summary of actions taken to address the safety and wellbeing of Indigenous women, girls and 2SLGBT • High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy • Novo Nordisk Enters Into Exclusive Negotiations to Acquire a Controlling Stake in BICORP, to Be Followed by a Tender Offer on Al • Expro Wins Well Intervention and Integrity Contract for Major Project in Uganda • Statement by the Prime Minister on Canadian Armed Forces Day • Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in C • Dorsett Wanchai Marks World Environment Day 2023 with Bold Paperless and Plastic-Free Sustainability Initiatives • Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejectio • Sustainability as a Success Factor: OQ Chemicals Launches Biobased Oxbalance TCD Alcohol DM • Bijou Ikli named new CEO by Florida Assisted Living Association • VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor, VIC-1911, and G12C Inhibitor, S • BenevolentAI Progresses BEN-34712 for the Potential Treatment of ALS into IND-Enabling Studies • Tips for a smooth transition to senior living from the San Luis Obispo assisted living professionals • Statement by the Prime Minister to mark four years since the publication of the final report of the National Inquiry into Missin • Transgene Presents Immunological Data Demonstrating that TG4001, a Novel Therapeutic Cancer Vaccine, Can Induce T-cell Responses

MaaT Pharma Announces 2022 Annual Results and Provides a Business Overview

LYON, France , March 30 /Businesswire/ - With the construction of our manufacturing facility and the roadmap we shared at the beginning of the year, we are excited with the progress we have made to advance our microbiome therapies that we believe could become a new pillar in treating cancer.